Stay updated on Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The page now lists Revision: v3.6.4, replacing the previous v3.6.3. This appears to be a minor revision tag update with no substantive changes to the study content in the provided data.
    Difference
    0.0%
    Check dated 2026-07-28T03:00:13.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    A new PubMed publication citation by Weidinger et al. was added to the Publications section for the study. The page version was updated from v3.6.2 to v3.6.3.
    Difference
    0.0%
    Check dated 2026-07-06T16:41:02.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The page's revision tag advanced from v3.6.0 to v3.6.2, signaling a minor update to the page's documentation. The change does not modify trial content or functionality.
    Difference
    0.0%
    Check dated 2026-06-29T08:40:30.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    Recruitment status updated to 'No longer looking for participants' and new help sections were added (How to Read a Study Record, Common Questions, How to Join a Study). The page introduces an Intervention/Treatment section header while removing the previous Intervention / Treatment header, and the site revision version updated to v3.6.0.
    Difference
    0.2%
    Check dated 2026-06-15T08:11:38.000Z thumbnail image
  8. Check
    59 days ago
    Change Detected
    Summary
    The revision tag on the page was updated from Revision: v3.5.4 to Revision: v3.5.5. This indicates a newer page version.
    Difference
    0.0%
    Check dated 2026-06-08T04:16:47.000Z thumbnail image
  9. Check
    73 days ago
    Change Detected
    Summary
    Added a new publication reference about variable-dose versus continuous-dose abrocitinib in moderate-to-severe atopic dermatitis to the Publications section. This expands the study's literature context for readers.
    Difference
    0.0%
    Check dated 2026-05-24T14:53:19.000Z thumbnail image

Stay in the know with updates to Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial page.